65,437 trials
Gaucher Disease, Type 1
Primary: Change From Baseline to 12 Months in Hemoglobin Concentration for the 60 U/kg Treatment Group. — 2.429 g/dL — p=<0.0001
Attention Deficit Hyperactivity Disorder
Primary: To Assess the Safety and Tolerability of GTS21 (25 mg Tid, 75 mg Tid, 150 mg Tid). — 67; 72; 100 % of subjects
HIV
Primary: Change From Baseline in Fasting Triglyceride (TG) Levels in the Lipid Evaluable (LE) Set at Week12 — 113.7; 114.2; 22.0; 8.1 milligram per deciliters (mg/dL)
Low Back Pain
Primary: Average Pain Over the Last 24 Hours Scores at Week 12 of the Double-blind Phase. — 7.24; 7.17; 2.57; 2.56 Units on a scale — p=.0104
Rotavirus Infections · Gastroenteritis
Primary: Geometric Mean Titer(s) of Poliovirus Types 1, 2, and 3, Measured Approximately 42 Days Postdose 3 — 888.0; 1139; 814.9; 814.5 Geometric Mean Titer (GMT) — p=<0.001
Genital Neoplasms, Female · Fallopian Tube Neoplasms · Ovarian Neoplasms
Primary: Progression Free Survival (PFS) — 20.0; 22.2 Months — p=0.199
Pneumonia
Primary: Colonization of the Oral Cavity by Respiratory Pathogens (on Teeth/Denture/Buccal Mucosa) as Determined by Quantitative Cultures Expressed as Colony Forming Units (Cfu)…
Non-small Cell Lung Cancer
Primary: Progression-Free Survival (PFS) — 9.95; 6.83 Months — p=0.0618
Overactive Bladder
Primary: Change From Baseline in Mean Number of Urgency Urinary Incontinence (UUI) Episodes Per 24 Hours at Week 12. — -1.01; -1.35; -1.40 UUI Episodes — p=0.002
Pulmonary Hypertension
Primary: Change in the 6-minute Walk Distance From Baseline at Week 12 in Participants Who Entered the Study From Part I — 84.2 meters
Psychosis
Primary: Number of Participants Who Experienced an Adverse Event — 44; 44 Participants
Ileus
Primary: Percentage of Patients Who Died — 0.4; 1.0 Percent of participants — p=0.0007
Cataract Extraction · Corneal Astigmatism
Primary: High and Low Contrast Acuity — 0.0855; 0.065; 0.082 logMAR
Leukemia · Myelodysplastic Syndromes
Primary: Overall Survival (OS) — 7.23; 9.43 Months — p=0.28
Pain · Osteoarthritis, Hip · Osteoarthritis, Knee
Primary: Analgesic Effect as Assessed by Brief Pain Inventory (BPI) Item 5 Score (Pain on Average) — 6.4; 6.4; 6.5; 6.6 units on a scale — p=0.1212